Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Effects of Cumulative Herpesviridae and Toxoplasma gondii Infections on Cognitive Function in Healthy, Bipolar, and Schizophrenia Subjects.

Hamdani N, Daban-Huard C, Godin O, Laouamri H, Jamain S, Attiba D, Delavest M, Lépine JP, Le Corvoisier P, Houenou J, Richard JR, Yolken RH, Krishnamoorthy R, Tamouza R, Leboyer M, Dickerson FB.

J Clin Psychiatry. 2017 Jan;78(1):e18-e27. doi: 10.4088/JCP.15m10133.

PMID:
27929612
2.

Serum antibodies to Toxoplasma gondii and Herpesvidae family viruses in individuals with schizophrenia and bipolar disorder: a case-control study.

Tedla Y, Shibre T, Ali O, Tadele G, Woldeamanuel Y, Asrat D, Aseffa A, Mihret W, Abebe M, Alem A, Medhin G, Habte A.

Ethiop Med J. 2011 Jul;49(3):211-20.

PMID:
21991754
3.

[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].

Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B.

Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. Epub 2008 Jul 9. French.

PMID:
19081451
4.

Serological evidence of exposure to Herpes Simplex Virus type 1 is associated with cognitive deficits in the CATIE schizophrenia sample.

Yolken RH, Torrey EF, Lieberman JA, Yang S, Dickerson FB.

Schizophr Res. 2011 May;128(1-3):61-5. doi: 10.1016/j.schres.2011.01.020. Epub 2011 Feb 24.

PMID:
21353483
5.

Cytomegalovirus seropositivity and serointensity are associated with hippocampal volume and verbal memory in schizophrenia and bipolar disorder.

Houenou J, d'Albis MA, Daban C, Hamdani N, Delavest M, Lepine JP, Vederine FE, Carde S, Lajnef M, Cabon C, Dickerson F, Yolken RH, Tamouza R, Poupon C, Leboyer M.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:142-8. doi: 10.1016/j.pnpbp.2013.09.003. Epub 2013 Sep 29.

6.

The Impact of Obesity on Cognitive Functioning in Euthymic Bipolar Patients: A Cross-Sectional and Longitudinal Study.

Mora E, Portella MJ, Martinez-Alonso M, Teres M, Forcada I, Vieta E, Mur M.

J Clin Psychiatry. 2017 Sep/Oct;78(8):e924-e932. doi: 10.4088/JCP.16m10968.

PMID:
28994517
7.

Antibodies to Toxoplasma gondii and cognitive functioning in schizophrenia, bipolar disorder, and nonpsychiatric controls.

Dickerson F, Stallings C, Origoni A, Katsafanas E, Schweinfurth L, Savage C, Khushalani S, Yolken R.

J Nerv Ment Dis. 2014 Aug;202(8):589-93. doi: 10.1097/NMD.0000000000000166.

PMID:
25010110
8.

Schizotypy and genetic loading for schizophrenia impact upon neuropsychological status in bipolar II and unipolar major depressive disorders.

Hori H, Matsuo J, Teraishi T, Sasayama D, Kawamoto Y, Kinoshita Y, Hattori K, Hashikura M, Higuchi T, Kunugi H.

J Affect Disord. 2012 Dec 15;142(1-3):225-32. doi: 10.1016/j.jad.2012.04.031. Epub 2012 Jun 19.

PMID:
22717107
9.

Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder.

Dickerson FB, Boronow JJ, Stallings C, Origoni AE, Cole S, Krivogorsky B, Yolken RH.

Biol Psychiatry. 2004 Mar 15;55(6):588-93.

PMID:
15013827
10.

The association among smoking, HSV-1 exposure, and cognitive functioning in schizophrenia, bipolar disorder, and non-psychiatric controls.

Dickerson F, Adamos MB, Katsafanas E, Khushalani S, Origoni A, Savage CLG, Schroeder J, Schweinfurth LAB, Stallings C, Sweeney K, Yolken R.

Schizophr Res. 2016 Oct;176(2-3):566-571. doi: 10.1016/j.schres.2016.05.022. Epub 2016 Jun 1.

PMID:
27262384
11.

Maternal T. gondii, offspring bipolar disorder and neurocognition.

Freedman D, Bao Y, Shen L, Schaefer CA, Brown AS.

Psychiatry Res. 2016 Sep 30;243:382-9. doi: 10.1016/j.psychres.2016.06.057. Epub 2016 Jul 7.

12.
13.

Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder.

Jabben N, Arts B, van Os J, Krabbendam L.

J Clin Psychiatry. 2010 Jun;71(6):764-74. doi: 10.4088/JCP.08m04837yel. Epub 2010 Jan 26.

PMID:
20122370
15.

Cognitive functioning in euthymic bipolar I and bipolar II patients.

Dittmann S, Hennig-Fast K, Gerber S, Seemüller F, Riedel M, Emanuel Severus W, Langosch J, Engel RR, Möller HJ, Grunze HC.

Bipolar Disord. 2008 Dec;10(8):877-87. doi: 10.1111/j.1399-5618.2008.00640.x.

PMID:
19594503
16.

Anti-Toxoplasma gondii antibodies in patients with schizophrenia--preliminary findings in a Turkish sample.

Cetinkaya Z, Yazar S, Gecici O, Namli MN.

Schizophr Bull. 2007 May;33(3):789-91. Epub 2007 Apr 2.

17.

Cognitive deterioration among bipolar disorder patients infected by Toxoplasma gondii is correlated to interleukin 6 levels.

Hamdani N, Daban-Huard C, Lajnef M, Gadel R, Le Corvoisier P, Delavest M, Carde S, Lépine JP, Jamain S, Houenou J, Galeh B, Richard JR, Aoki M, Charron D, Krishnamoorthy R, Yolken R, Dickerson F, Tamouza R, Leboyer M.

J Affect Disord. 2015 Jul 1;179:161-6. doi: 10.1016/j.jad.2015.03.038. Epub 2015 Apr 1.

PMID:
25863913
18.

Cognitive Deficits in Patients With Neuropsychiatric Symptoms: A Comparative Study Between Behavioral Variant Frontotemporal Dementia and Primary Psychiatric Disorders.

Vijverberg EGB, Schouws S, Meesters PD, Verwijk E, Comijs H, Koene T, Schreuder C, Beekman A, Scheltens P, Stek M, Pijnenburg Y, Dols A.

J Clin Psychiatry. 2017 Sep/Oct;78(8):e940-e946. doi: 10.4088/JCP.16m11019.

PMID:
28749089
19.

[Neurocognitive function in clinically stable patients with schizophrenia or bipolar disorder and normal controls].

Konstantakopoulos G, Ioannidi N, Patrikelis P, Soumani A, Oulis P, Sakkas D, Papadimitriou GN, Ploumpidis D.

Psychiatriki. 2011 Jul-Sep;22(3):195-206. Greek, Modern.

PMID:
21971195
20.

A controlled prospective study of toxoplasma gondii infection in individuals with schizophrenia: beyond seroprevalence.

Hinze-Selch D, Däubener W, Eggert L, Erdag S, Stoltenberg R, Wilms S.

Schizophr Bull. 2007 May;33(3):782-8. Epub 2007 Mar 26. Erratum in: Schizophr Bull. 2011 May;37(3):652.

Supplemental Content

Support Center